Cosciens Biopharma INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
Peter Puccetti has sold his interest in Goodwood Inc., significantly reducing his beneficial ownership in Cosciens Biopharma to 0.5%.
NASDAQ
SCHEDULE 13D/A: COSCIENS Biopharma Reconstitutes Board Following Agreement with Activist Investor Goodwood
COSCIENS Biopharma Inc. has announced a consensual reconstitution of its board of directors and a postponement of its annual meeting, following a resolution agreement with activist investor Goodwood.